Morgan Stanley Adjusts Palo Alto Networks Price Target Amid Shifting Demand Trends OpenAI Poised for Confidential IPO Filing Signaling Acceleration in AI Public Listings Workday Shares Rise 5 as AI Strength Drives Margin Forecast Upgrade Bessent Forecasts Substantial Disinflation as Warsh Poised to Lead Federal Reserve Enhanced Games Backed by Donald Trump Jr Set to Launch on Sunday Expanding Beyond Controversial Competition Alberta Separation Referendum Carney Highlights Provinces Essential Role in Canadian Economy LUCD Q1 2026 Earnings EPS Misses Estimates Amid PreRevenue Status BOF Q1 2026 Earnings EPS Loss of 012 Amid Operational Challenges XOMAP Q1 2026 Earnings Perpetual Preferred Faces Steep EPS Miss Amid Limited Revenue Visibility LEDS Q1 2026 Earnings Narrower Loss Reported Amidst Limited Analyst Coverage EFSCP Q1 2026 Earnings Preferred Stock Steady as Common EPS Misses Estimates Verrica Pharmaceuticals Q1 2026 Earnings EPS Miss Amid PreRevenue Stage Stock Rises 271 Galaxy Payroll Group Limited GLXG Hits 101 After Sharp 1855 Decline Support and Resistance in Focus Philip Morris International Edges Lower as Stock Consolidates Near Key Levels LMP Capital and Income Fund SCD Modestly Higher as Price Approaches Key Resistance SunCar Technology Warrant SDAWW Slides 16 Penny Stock Pressure at 005 Prestige Consumer Healthcare Inc PBH Edges Higher Amid Defensive Appeal University of Manchester Pioneers Universal Work Placement Initiative Potentially Reshaping Higher Education HSLV Q1 2026 Earnings Massive EPS Surprise Despite No Reported Revenue XPO Inc XPO Posts Modest Gains as Logistics Demand Holds Steady VELO Q1 2026 Earnings Surprise EPS Beat Drives DoubleDigit Stock Surge ACGLN Q1 2026 Earnings Preferred Share EPS Falls Slightly Short of Estimates Stock Edges Higher Energy Recovery Inc Q1 2026 Earnings EPS Misses Estimates as Stock Gains 267 CNO Q1 2026 Earnings EPS Surges Past Estimates as Stock Edges Lower IEX Q1 2026 Earnings EPS Surpasses Estimates on Strong Execution MWA Q1 2026 Earnings EPS Surpasses Estimates by 65 Amid Strong Operational Performance Lineage Cell Therapeutics Inc LCTX Q1 2026 Earnings EPS Misses Estimates Amid Pipeline Progress Stock Rises 308